Patents by Inventor Hossein Omidian

Hossein Omidian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10878150
    Abstract: Disclosed approaches for optimizing netlist loops include associating loop optimization methods with loop patterns in a computer memory. A circuit design can be synthesized into a netlist, and netlist loops that conform to the loop patterns can be identified. For each matching netlist loop, a loop optimization method associated with the loop pattern to which the netlist loop conforms can be selected. For each netlist loop, the loop optimization method associated with the loop pattern to which the netlist loop conforms can be performed to modify logic of the netlist loop in the netlist.
    Type: Grant
    Filed: September 17, 2019
    Date of Patent: December 29, 2020
    Assignee: Xilinx, Inc.
    Inventor: Hossein Omidian Savarbaghi
  • Publication number: 20200108028
    Abstract: A therapeutic dosage form includes a pharmaceutically active ingredient, a crosslinked polyacid, and a linear polyacids. The crosslinked polyacid is insoluble in water, and the linear polyacid is soluble in water. An example of a crosslinked polyacids is sodium carboxymethylcellulose. The linear polyacid possesses sufficient binding sites to form a stable complex with the pharmaceutically active ingredient. An example of a linear polyacid is polymethacrylic acid. The ingredients are formed into a tablet or capsule, either admixed, in layers, or separated by a coating. Abuse is deterred in that crushing causes the active ingredient to be bound and not abusable, and placing the dosage in solution causes a strong complex to be formed between the polyacid and the active ingredient, including a solution with ethanol.
    Type: Application
    Filed: October 8, 2019
    Publication date: April 9, 2020
    Inventors: Hossein Omidian, David J. Mastropietro, Srinath Muppalaneni
  • Publication number: 20190046521
    Abstract: Abuse-resistant therapeutic pharmaceutical formulations include a cationic drug and at least one anionic polymer. Particular arrangements of the cationic drug and the at least one anionic polymer prevent the cationic drug from being extracted from the formulations in solvents and conditions commonly used by drug abusers attempting to isolate the cationic drug from its formulation.
    Type: Application
    Filed: September 5, 2018
    Publication date: February 14, 2019
    Inventors: Hossein Omidian, Yogesh N. Joshi, Rand Husni Mahmoud Ahmad
  • Publication number: 20180303824
    Abstract: The invention enables the formation of prescription drugs less likely to be abused. Different approaches are employed that can potentially deter abuse by reducing the efficacy of main processes utilized by abusers to speed drug absorption and enhance its effect. Pharmaceutical compositions of the invention incorporate one or more of the following elements: super water-absorbency, alcohol absorption, organic binding agents, inorganic binding agents, adsorption, and tough platforms. These compositions function by preventing the isolation and concentration of drug constituents for misuse and/or preventing excessive intake. Thus, the invention encompasses various compositions and methods for reducing abuse of pharmaceutical products and alcohol.
    Type: Application
    Filed: October 21, 2016
    Publication date: October 25, 2018
    Inventors: Hossein Omidian, Srinath Muppalaneni, Yogesh N. Joshi, David J. Mastropietro
  • Publication number: 20160213628
    Abstract: A therapeutic dosage form includes a pharmaceutically active ingredient, a crosslinked polyacid, and a linear polyacids. The crosslinked polyacid is insoluble in water, and the linear polyacid is soluble in water. The linear polyacid possesses sufficient binding sites to form a stable complex with the pharmaceutically active ingredient. The ingredients are formed into a tablet or capsule, either admixed, in layers, or separated by a coating. Abuse is deterred in that crushing causes the active ingredient to be bound and not abusable, and placing the dosage in solution causes a strong complex to be formed between the polyacid and the active ingredient, including a solution with ethanol. Other therapeutic dosage forms for reducing the incidence of tampering and abuse of pharmaceutical products and alcohol, and specifically preventing the isolation and concentration of drug constituents for misuse, and preventing excessive intake are also disclosed.
    Type: Application
    Filed: September 9, 2014
    Publication date: July 28, 2016
    Inventors: Hossein Omidian, David J. Mastropietro, Srinath Muppalaneni
  • Patent number: 7988992
    Abstract: The present invention features modified superporous hydrogels (SPHs) and methods for their formation. The SPHs of the present invention are prepared by careful selection of the hydrophobic/hydrophilic reactive ingredients and by harmonizing the foaming and polymerization reactions, which results in the formation of SPHs having a homogeneous structure and favorable physical and mechanical properties, including swelling, strength, ruggedness, and resiliency. The SPHs of the present invention are particularly useful when employed in very harsh swelling environments, such as the low pH environment of the gastric fluid of the stomach, for extended periods of time.
    Type: Grant
    Filed: July 6, 2007
    Date of Patent: August 2, 2011
    Assignee: KOS Life Sciences Abbott Laboratories
    Inventors: Hossein Omidian, Jose G. Rocca
  • Publication number: 20080206339
    Abstract: The invention relates to methods for preparing superporous hydrogels (SPH) that are very-pure and have desirable swelling properties necessary for commercial use, such as in food and pharmaceutical applications. Such methods include simultaneous use of low and high glass transition monomers to improve impurity and swelling profiles of the SPH, use of an integration means to prepare a very homogenous superporous hydrogel foam, washing the superporous hydrogel in a washing solution comprising different ratios of solvent to non-solvent (e.g., water/alcohol), use of a chemically-induced expansion/contraction process to enhance the efficiency of the multiple washing process and to fully structuralize the SPH, and employing one or more separation techniques, such as rubbing, filtration, centrifugation, compression and cutting to increase the efficiency of the purification process and to enhance the SPH swelling properties.
    Type: Application
    Filed: February 25, 2008
    Publication date: August 28, 2008
    Applicant: Abbott Laboratories
    Inventors: Hossein Omidian, Cristian Gavrilas, Wenli Han, Ge Li, Jose G. Rocca
  • Publication number: 20080089940
    Abstract: The present invention features modified superporous hydrogels (SPHs) and methods for their formation. The SPHs of the present invention are prepared by careful selection of the hydrophobic/hydrophilic reactive ingredients and by harmonizing the foaming and polymerization reactions, which results in the formation of SPHs having a homogeneous structure and favorable physical and mechanical properties, including swelling, strength, ruggedness, and resiliency. The SPHs of the present invention are particularly useful when employed in very harsh swelling environments, such as the low pH environment of the gastric fluid of the stomach, for extended periods of time.
    Type: Application
    Filed: July 6, 2007
    Publication date: April 17, 2008
    Inventors: Hossein Omidian, Jose Rocca
  • Patent number: 7056957
    Abstract: The present invention features a method for the formation of superporous hydrogels using an ion-equilibration technique. Anionic polysaccharides are included in the hydrogel reaction mixture and cations are introduced either during or after hydrogel formation. Properties of the resulting hydrogel can be subsequently adjusted by treating the cation-complexed gel with a different cation or cation mixture under equilibrating conditions. It has been found that by properly adjusting the cations and the sequence in which they are used in the equilibration process, superporous hydrogels can be formed that are highly absorbent while maintaining favorable structural properties, including strength, ruggedness, and resiliency. It has also been found that applying appropriate dehydration conditions to them after their formation can further stabilize the superporous hydrogels formed by the method of the invention.
    Type: Grant
    Filed: April 20, 2004
    Date of Patent: June 6, 2006
    Assignee: KOS Pharmaceuticals, Inc.
    Inventors: Hossein Omidian, Jose Gutierrez-Rocca
  • Patent number: 6960617
    Abstract: Hydrogels having improved elasticity and mechanical strength properties are obtained by subjecting a hydrogel formulation containing a strengthening agent to chemical or physical crosslinking conditions subsequent to initial gel formation. Superporous hydrogels having improved elasticity and mechanical strength properties are similarly obtained whenever the hydrogel formulation is provided with a foaming agent. Interpenetrating networks of polymer chains comprised of primary polymer(s) and strengthening polymer(s) are thereby formed. The primary polymer affords capillary-based water sorption properties while the strengthening polymer imparts significantly enhanced mechanical strength and elasticity to the hydrogel or superporous hydrogel. Suitable strengthening agents can be natural or synthetic polymers, polyelectrolytes, or neutral, hydrophilic polymers.
    Type: Grant
    Filed: April 22, 2003
    Date of Patent: November 1, 2005
    Assignee: Purdue Research Foundation
    Inventors: Hossein Omidian, Yong Qiu, Shicheng Yang, Dukjoon Kim, Haesun Park, Kinam Park
  • Publication number: 20040224021
    Abstract: The present invention features a method for the formation of superporous hydrogels using an ion-equilibration technique. Anionic polysaccharides are included in the hydrogel reaction mixture and cations are introduced either during or after hydrogel formation. Properties of the resulting hydrogel can be subsequently adjusted by treating the cation-complexed gel with a different cation or cation mixture under equilibrating conditions. It has been found that by properly adjusting the cations and the sequence in which they are used in the equilibration process, superporous hydrogels can be formed that are highly absorbent while maintaining favorable structural properties, including strength, ruggedness, and resiliency. It has also been found that applying appropriate dehydration conditions to them after their formation can further stabilize the superporous hydrogels formed by the method of the invention.
    Type: Application
    Filed: April 20, 2004
    Publication date: November 11, 2004
    Inventors: Hossein Omidian, Jose Gutierrez-Rocca
  • Publication number: 20030232895
    Abstract: Hydrogels having improved elasticity and mechanical strength properties are obtained by subjecting a hydrogel formulation containing a strengthening agent to chemical or physical crosslinking conditions subsequent to initial gel formation. Superporous hydrogels having improved elasticity and mechanical strength properties are similarly obtained whenever the hydrogel formulation is provided with a foaming agent. Interpenetrating networks of polymer chains comprised of primary polymer(s) and strengthening polymer(s) are thereby formed. The primary polymer affords capillary-based water sorption properties while the strengthening polymer imparts significantly enhanced mechanical strength and elasticity to the hydrogel or superporous hydrogel. Suitable strengthening agents can be natural or synthetic polymers, polyelectrolytes, or neutral, hydrophilic polymers.
    Type: Application
    Filed: April 22, 2003
    Publication date: December 18, 2003
    Inventors: Hossein Omidian, Yong Qiu, Shicheng Yang, Dukjoon Kim, Haesun Park, Kinam Park